Viant to Manufacture Venclose's RF Ablation Catheter for Venous Reflux Disease


February 7, 2019—Venclose Inc. and Viant announced a partnership for the manufacture of Venclose’s next-generation Venclose radiofrequency (RF) ablation catheter. The Venclose RF system is designed to close the damaged vein and restore healthy blood flow in patients with venous reflux disease. The Venclose RF system is available in the United States and Europe.

Venclose, based in San Jose, California, is a developer of treatments for chronic venous insufficiency. Viant is an ISO-certified medical device contract manufacturer with headquarters in Foxborough, Massachusetts. The Venclose system will be transferred to Viant’s manufacturing facility in Costa Rica in Q3 2019 to allow for market expansion.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.